Astrelis
Dialysis facility · Maplewood, MN

DaVita Maplewood Dialysis Center

CCN 242512Latest FY 2025
Cost-report basis
HCRIS · as filed
Not audited by Astrelis

Operating margin: +28.9% in FY2025, the 80th percentile of 7,109 dialysis facilities in the FY2025 pool. Total operating revenue: $3.8M in FY2025, the 53rd percentile of 7,110 dialysis facilities in the FY2025 pool. Total margin (including nonoperating): +29.0% in FY2025, the 82nd percentile of 7,110 dialysis facilities in the FY2025 pool. Figures as filed; not audited by Astrelis.

The read

A dialysis facility in Maplewood, MN. It ran an operating surplus of 28.9% in FY25 on $3.8M of operating revenue. Operating margin improved from 25.8% in FY20 to 28.9% in FY25.

Operating margin · FY25
+28.9%
Astrelis calculation · as-filed inputs
▲ 4.7 pts vs FY24
vs dialysis facilities80th pctl of 7,109 (FY25 pool)
pool: this metric's own fiscal year · excludes historical, non-panel, and out-of-range values
Days cash on hand
Astrelis calculation unavailable
Total operating revenue · FY25
$3.8M
Astrelis calculation · as-filed inputs
▲ $0.3M vs FY24
vs dialysis facilities53rd pctl of 7,110 (FY25 pool)
pool: this metric's own fiscal year · excludes historical, non-panel, and out-of-range values
Total margin · incl. nonoperating · FY25
+29.0%
Astrelis calculation · as-filed inputs
▲ 4.7 pts vs FY24
vs dialysis facilities82nd pctl of 7,110 (FY25 pool)
pool: this metric's own fiscal year · excludes historical, non-panel, and out-of-range values

Where DaVita Maplewood Dialysis sits among dialysis facilities

Operating margin · FY25 pool · n = 7,109 of 7,234 filed

Each point is one dialysis facility in the national FY25 distribution for this provider type, placed by operating margin. Facilities are not matched on size, case mix, or market; that is the matched-peer comparison in the paid benchmark. The dialysis facility FY25 median is +16.8%. Descriptive context only, not a ranking.

-20%-10%0%+10%+20%dialysis facility median +16.8%DaVita Maplewood +28.9%
One dialysis facilityDaVita Maplewooddialysis facility median

The money

$ thousands · HCRIS cost-report basis · as filed, QA-gated

Ratios tell you how this dialysis facility is doing. Statements tell you what kind of organization it is, and where the money comes from. Every figure below traces to a public cost-report filing, shown as filed. A ratio computes only when every input is reported in the filing (otherwise its cell states which input is Not reported in source); a year whose balance sheet does not reconcile is labeled, and its derived ratios read Astrelis calculation unavailable. Not audited by Astrelis.

Operating margin
+28.9% (FY25)
Operating income ÷ total operating revenue
Astrelis calculation · HCRIS WS G-3
Total margin
+29.0% (FY25)
Net income ÷ total revenue incl. nonoperating
Astrelis calculation · HCRIS WS G-3
Days cash on hand
Not reported in source
Cash & investments ÷ daily operating expense
Astrelis calculation · HCRIS WS G / G-3
Current ratio
304.86× (FY25) — outside expected range; computed from the filed statement and not ranked against peers
Total current assets ÷ current liabilities
Astrelis calculation · HCRIS WS G
Equity financing ratio
98% (FY25)
Total net assets ÷ total assets
Astrelis calculation · HCRIS WS G
Days in net patient A/R
47d (FY25)
Net patient receivables ÷ (net patient revenue ÷ 365), same fiscal year
Astrelis calculation · HCRIS WS G / G-3
$ in thousands
Line itemFY23FY24FY25
Patient revenue3,1883,5073,762
Total operating revenue3,1883,5073,762
Total operating expenses2,4032,6562,673
Operating income7868511,089
Operating margin %+24.6%+24.3%+28.9%
Other non-operating, net021
Net income7868531,090
Net income %+24.6%+24.3%+29.0%
— = Not reported in source for that year.
HCRIS CMS-265 cost report · $ thousands · FY20–FY25 · operating revenue reflects net patient service revenue · FY20–21 may include COVID-era relief funding

How it operates

quality & operational context · CMS public reporting

The metrics this dialysis facility type is judged on: care quality, patient experience, and scale. Each is labeled by provenance class and public source; descriptive context only, never a ranking or adequacy claim. Provenance labels: Reported value is copied from the named public source; Astrelis calculation is a formula applied to unchanged reported inputs, with the formula shown; Illustrative estimate is a benchmark gap, multiplier, or scenario — never a measurement.

Quality star
4★
Reported value2026
CMS Dialysis Compare
Total treatments
9,294
Reported value2025
HCRIS CMS-265
Cost per treatment ($)
287.61
Astrelis calculation2025
HCRIS CMS-265
Net revenue per treatment ($)
404.79
Astrelis calculation2025
HCRIS CMS-265
Dialysis stations
16
Reported value2026
CMS Dialysis Facility Compare
Modalities offered
In-center hemodialysis
Reported value2026
CMS Dialysis Facility Compare

Trajectory

Cost-report basis · 6 reporting years
Operating margin
+25.8%+31.6%+29.2%+24.6%+24.3%+28.9%FY20FY21FY22FY23FY24FY25
Days cash on hand
Not available

State context

Maplewood, MN
Located in Maplewood, MN. County-level statistics: linkage not established — this record's county mapping is not verified in the resolved spine, and we never place a facility in a county by guesswork. State-level context appears here once a state aggregate layer lands.
Operating margin vs its peer poolFY25Astrelis calculation

28.9% operating margin — 80th percentile of 7,109 peers (FY25 pool).

The Board Briefing

Operating margin improved 4.7 points vs FY24 — the briefing traces why, line by line.

Reserve The Board Briefing →
Performance Benchmark Report

($405 revenue vs $288 cost per treatment) = $117 per treatment above cost × 9,294 treatments ≈ $1.1M net spread at current volume · method
Reserve Performance Benchmark Report →
How we calculated this

Operating margin vs its peer pool: FY25 pool · n = 7,109.

Performance Benchmark Report: FY25 peer pool · n = 7,109 · conservative low band; acuity limits stated in the report.

Report coverage: Limited Facility Benchmark. 9 of 10 facility measures available from public sources. The report covers the available measures against their peer benchmarks; measures the public record does not carry become findings. Coverage is disclosed here before you reserve, and thin data is never a decline reason. The refund guarantee stands: if we cannot deliver the published scope, you pay nothing.

Portfolio Performance Review

A roster-priced triage of the per-facility benchmarks: every facility on your roster, benchmarked and sorted. Requires only a CCN roster.

From $7,500Founding Edition · built to order, first edition · priced by roster size · invoice after coverage confirmation · within 30 days
Request: scoped and quoted before any invoice. No payment is collected on this site.

Cite this page

release 2321a4fc37a7 · 2026-10-22

Astrelis Atlas, "Davita Maplewood Dialysis Center", https://astrelis.co/providers/dialysis/242512, release 2321a4fc37a7 (2026-10-22). Figures as filed in the named public sources; not audited by Astrelis.

Machine-readable twin of this page: astrelis.co/providers/dialysis/242512.md (Markdown, the same figures with their fiscal years, pools and definitions). Last modified: release 2321a4fc37a7, 2026-10-22. Figures are as filed in the named public sources. Astrelis is not a CPA firm and performs no audit, review or attestation of any facility.

build 2321a4fc37a7 · 2026-10-22 · dev